Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | PDE9A | O76083 | 1/20 | 0.30 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21396919 | 0.92 | PDE9A (0.34) | ACHEPTGDR2PDE9APDE1C | |
| SCHEMBL21396585 | 0.90 | CYP11B2 (0.32) | CYP11B2 | |
| SCHEMBL21397181 | 0.90 | CYP11B2 (0.33) | CYP11B2 | |
| SCHEMBL21378074 | 0.89 | PTGDR2 (0.33) | PTGDR2PDE9APDE1C | |
| SCHEMBL21378032 | 0.81 | ACHE (0.40) | CYP11B2ACHEGRIN1GRIN2A | |
| SCHEMBL21377994 | 0.81 | ACHE (0.40) | CYP11B2ACHEGRIN1GRIN2A | |
| SCHEMBL21377979 | 0.81 | ACHE (0.40) | CYP11B2ACHEGRIN1GRIN2A | |
| SCHEMBL21396830 | 0.81 | PDE9A (0.31) | PDE9APDE1C | |
| SCHEMBL21397090 | 0.81 | TSPO (0.31) | PDE9APDE1C | |
| SCHEMBL21397080 | 0.80 | KDR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190292181-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | Kyulux North America, Inc. | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292181-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | CYP11B2 1221/4885ACHE 251/4885GRIN1 1201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.